Login / Signup

Estimating the costs of blindness and moderate to severe visual impairment among people with diabetes in India.

Stuart ReddingRobert AndersonRajiv RamanSobha SivaprasadRaphael Wittenbergnull null
Published in: BMJ open (2023)
This is the first study to estimate the cost of blindness and MSVI for people aged 40 years and over with diabetes in India. The annual cost to the Indian economy is substantial. This cost will be expected to fall if a successful screening and treatment plan is introduced in India. Further work is suggested using more robust data, when available, to estimate the loss of productivity and loss of QALYs, as this would be worthwhile.
Keyphrases
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • big data
  • early onset
  • electronic health record
  • adipose tissue
  • insulin resistance
  • artificial intelligence
  • combination therapy